Study paves the way for improving personalized treatment of patients with glioblastoma

A study led by the ITACA Institute of the Universitat Politècnica de València, with the participation of the Institut Català d'Oncologia (ICO), the Institut Investigació Germans Trias I Pujol (IGTP) and the Hospital Clinic de Barcelona, opens up a novel approach for improving personalized treatments for patients with glioblastoma, one of the most aggressive types of cancer in existence today.

Related Keywords

Barcelona ,Comunidad Autonoma De Cataluna ,Spain ,Germany ,New York ,United States ,Columbia University ,Germans ,Institut Investigaci ,Triasi Pujol ,Institut Catal ,Biomedical Data Science Lab Bdslab ,Institute Of The Universitat Polit ,Universitat Polit ,Germans Triasi Pujol ,Hospital Clinic De Barcelona ,Del Mar ,Biomedical Data Science Lab ,Glioblastoma ,Evacizumab ,Flood ,Blood Vessels ,Dancer ,Efficacy ,Research ,